XML 70 R43.htm IDEA: XBRL DOCUMENT
v3.24.0.1

OPERATING SEGMENTS (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
OPERATING SEGMENTS |
Schedule of financial information for each of the entity's reportable segments, including the impact of the preceding changes on previously reported full year 2021 net sales and operating income | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31, 2022
​ |  | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
​ | ​ | 2022 Reported | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Fixed | ​ | ​ | ​ | 2022 Reported
​ | ​ | Valued at 2022 |  | ​ | ​ |  | Currency | ​ |  | Valued at 2023
(millions) | ​ | Fixed Currency Rates |  | Other | ​ |  | Rate Change | ​ |  | Fixed Currency Rates
Net Sales | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ |  | ​ | ​
Global Industrial | ​ | ​ | $6,944.0 | ​ | ​ | ​ | $- | ​ | ​ | ​ | ​ | ($207.7) | ​ | ​ | ​ | ​ | $6,736.3
Global Institutional & Specialty | ​ | ​ | 4,480.0 | ​ | ​ | ​ | 10.2 | ​ | ​ | ​ | ​ | (75.9) | ​ | ​ | ​ | ​ | 4,414.3
Global Healthcare & Life Sciences | ​ | ​ | 1,570.0 | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | (64.2) | ​ | ​ | ​ | ​ | 1,505.8
Other | ​ | ​ | 1,355.0 | ​ | ​ | ​ | (10.2) | ​ | ​ | ​ | ​ | (31.5) | ​ | ​ | ​ | ​ | 1,313.3
Corporate | ​ | ​ | 124.1 | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | (0.4) | ​ | ​ | ​ | ​ | 123.7
Subtotal at fixed currency rates | ​ | ​ | 14,473.1 | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | (379.7) | ​ | ​ | ​ | ​ | 14,093.4
Effect of foreign currency translation | ​ | ​ | (285.3) | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | 379.7 | ​ | ​ | ​ | ​ | 94.4
Consolidated reported GAAP net sales | ​ | ​ | $14,187.8 | ​ | ​ | ​ | $- | ​ | ​ | ​ | ​ | $- | ​ | ​ | ​ | ​ | $14,187.8
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating Income | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Global Industrial | ​ | ​ | $977.0 | ​ | ​ | ​ | $0.8 | ​ | ​ | ​ | ​ | ($42.0) | ​ | ​ | ​ | ​ | $935.8
Global Institutional & Specialty | ​ | ​ | 634.5 | ​ | ​ | ​ | (1.6) | ​ | ​ | ​ | ​ | (11.2) | ​ | ​ | ​ | ​ | 621.7
Global Healthcare & Life Sciences | ​ | ​ | 205.0 | ​ | ​ | ​ | (1.8) | ​ | ​ | ​ | ​ | (9.9) | ​ | ​ | ​ | ​ | 193.3
Other | ​ | ​ | 212.8 | ​ | ​ | ​ | 2.6 | ​ | ​ | ​ | ​ | (5.5) | ​ | ​ | ​ | ​ | 209.9
Corporate | ​ | ​ | (416.7) | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | 2.3 | ​ | ​ | ​ | ​ | (414.4)
Subtotal at fixed currency rates | ​ | ​ | 1,612.6 | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | (66.3) | ​ | ​ | ​ | ​ | 1,546.3
Effect of foreign currency translation | ​ | ​ | (50.1) | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | 66.3 | ​ | ​ | ​ | ​ | 16.2
Consolidated reported GAAP operating income | ​ | ​ | $1,562.5 | ​ | ​ | ​ | $- | ​ | ​ | ​ | ​ | $- | ​ | ​ | ​ | ​ | $1,562.5
​ ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31, 2021
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2021 Reported |  | ​ | ​ | ​ | ​ |  | ​ | Fixed | ​ | ​ |  | 2021 Reported
​ | ​ | Valued at 2022 |  | Segment | ​ |  | Currency | ​ |  | Valued at 2023
(millions) | ​ | Fixed Currency Rates |  | Change | ​ |  | Rate Change | ​ |  | Fixed Currency Rates
Net Sales | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ |  | ​ | ​
Global Industrial | ​ | ​ | $6,086.8 | ​ | ​ | ​ | $- | ​ | ​ | ​ | ​ | ($178.3) | ​ | ​ | ​ | ​ | $5,908.5
Global Institutional & Specialty | ​ | ​ | 3,908.8 | ​ | ​ | ​ | 10.9 | ​ | ​ | ​ | ​ | (63.0) | ​ | ​ | ​ | ​ | 3,856.7
Global Healthcare & Life Sciences | ​ | ​ | 1,149.6 | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | (48.5) | ​ | ​ | ​ | ​ | 1,101.1
Other | ​ | ​ | 1,201.0 | ​ | ​ | ​ | (10.9) | ​ | ​ | ​ | ​ | (27.6) | ​ | ​ | ​ | ​ | 1,162.5
Corporate | ​ | ​ | 137.4 | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | 137.4
Subtotal at fixed currency rates | ​ | ​ | 12,483.6 | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | (317.4) | ​ | ​ | ​ | ​ | 12,166.2
Effect of foreign currency translation | ​ | ​ | 249.5 | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | 317.4 | ​ | ​ | ​ | ​ | 566.9
Consolidated reported GAAP net sales | ​ | ​ | $12,733.1 | ​ | ​ | ​ | $- | ​ | ​ | ​ | ​ | $- | ​ | ​ | ​ | ​ | $12,733.1
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating Income | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Global Industrial | ​ | ​ | $985.7 | ​ | ​ | ​ | $0.4 | ​ | ​ | ​ | ​ | ($42.7) | ​ | ​ | ​ | ​ | $943.4
Global Institutional & Specialty | ​ | ​ | 545.7 | ​ | ​ | ​ | (1.4) | ​ | ​ | ​ | ​ | (7.6) | ​ | ​ | ​ | ​ | 536.7
Global Healthcare & Life Sciences | ​ | ​ | 152.3 | ​ | ​ | ​ | (1.6) | ​ | ​ | ​ | ​ | (9.7) | ​ | ​ | ​ | ​ | 141.0
Other | ​ | ​ | 184.0 | ​ | ​ | ​ | 2.6 | ​ | ​ | ​ | ​ | (5.3) | ​ | ​ | ​ | ​ | 181.3
Corporate | ​ | ​ | (316.6) | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | 2.3 | ​ | ​ | ​ | ​ | (314.3)
Subtotal at fixed currency rates | ​ | ​ | 1,551.1 | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | (63.0) | ​ | ​ | ​ | ​ | 1,488.1
Effect of foreign currency translation | ​ | ​ | 47.5 | ​ | ​ | ​ | - | ​ | ​ | ​ | ​ | 63.0 | ​ | ​ | ​ | ​ | 110.5
Consolidated reported GAAP operating income | ​ | ​ | $1,598.6 | ​ | ​ | ​ | $- | ​ | ​ | ​ | ​ | $- | ​ | ​ | ​ | ​ | $1,598.6
Schedule of financial information for each of the entity's reportable segments | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Net Sales | ​ | ​ | Operating Income (Loss)
(millions) | ​ | 2023 | ​ | 2022 | ​ | 2021 | ​ | ​ | 2023 | ​ | 2022 | ​ | ​ | 2021
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Global Industrial | ​ | ​ | $7,193.1 | ​ | ​ | ​ | $6,736.3 | ​ | ​ | $5,908.5 | ​ | ​ | ​ | $1,080.7 | ​ | ​ | ​ | $935.8 | ​ | ​ | ​ | $943.4
Global Institutional & Specialty | ​ | ​ | 4,994.0 | ​ | ​ | ​ | 4,414.3 | ​ | ​ | 3,856.7 | ​ | ​ | ​ | 823.0 | ​ | ​ | ​ | 621.7 | ​ | ​ | ​ | 536.7
Global Healthcare & Life Sciences | ​ | ​ | 1,576.9 | ​ | ​ | ​ | 1,505.8 | ​ | ​ | 1,101.1 | ​ | ​ | ​ | 160.0 | ​ | ​ | ​ | 193.3 | ​ | ​ | ​ | 141.0
Other | ​ | ​ | 1,442.3 | ​ | ​ | ​ | 1,313.3 | ​ | ​ | 1,162.5 | ​ | ​ | ​ | 255.0 | ​ | ​ | ​ | 209.9 | ​ | ​ | ​ | 181.3
Corporate | ​ | ​ | 69.1 | ​ | ​ | ​ | 123.7 | ​ | ​ | 137.4 | ​ | ​ | ​ | (331.7) | ​ | ​ | ​ | (414.4) | ​ | ​ | ​ | (314.3)
Subtotal at fixed currency | ​ | ​ | 15,275.4 | ​ | ​ | ​ | 14,093.4 | ​ | ​ | 12,166.2 | ​ | ​ | ​ | 1,987.0 | ​ | ​ | ​ | 1,546.3 | ​ | ​ | ​ | 1,488.1
Effect of foreign currency translation | ​ | ​ | 44.8 | ​ | ​ | ​ | 94.4 | ​ | ​ | 566.9 | ​ | ​ | ​ | 5.3 | ​ | ​ | ​ | 16.2 | ​ | ​ | ​ | 110.5
Consolidated reported GAAP | ​ | ​ | $15,320.2 | ​ | ​ | ​ | $14,187.8 | ​ | ​ | $12,733.1 | ​ | ​ | ​ | $1,992.3 | ​ | ​ | ​ | $1,562.5 | ​ | ​ | ​ | $1,598.6
Schedule of net sales and long-lived assets at public exchange rates by geographic region | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Long-Lived Assets, net
(millions) | ​ | 2023 |  | 2022 |
United States | ​ | ​ | $2,708.6 | ​ | ​ | ​ | $2,508.9 | ​
Europe |  | ​ | 631.2 | ​ | ​ | ​ | 574.3 | ​
Asia Pacific | ​ | ​ | 213.0 | ​ | ​ | ​ | 210.3 | ​
Latin America |  | ​ | 175.1 | ​ | ​ | ​ | 146.5 | ​
Greater China |  | ​ | 167.4 | ​ | ​ | ​ | 176.6 | ​
India, Middle East and Africa | ​ | ​ | 68.2 | ​ | ​ | ​ | 64.1 | ​
Canada |  | ​ | 64.6 | ​ | ​ | ​ | 60.9 | ​
Total | ​ | ​ | $4,028.1 | ​ | ​ | ​ | $3,741.6 | ​
​ |  | ​ |  |  |  | ​ |  | ​

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment, including disclosure of changes for comparability of reportable segments. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References No definition available. + Details
Name: | ecl_ScheduleOfSegmentReportingInformationBySegmentIncludingChangesForComparabilityOfReportableSegmentsTableTextBlock
Namespace Prefix: | ecl_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration